Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024–2028
... obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 ... Read More
-
2024 Global Insulin Database and Analysis - Test Volume and Sales Segment Forecasts for Hospitals, Commercial Labs, POC Locations
... diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing Hospitals Commercial/Private Laboratories POC/Decentralized Testing Physician Offices/Group ... Read More
-
Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
... USD 23.02 billion in 2023 and expected to reach USD 28.35 billion in 2024, at a CAGR 23.76% to reach USD 102.40 billion by 2030. Regenerative medicine is an interdisciplinary field that applies engineering and ... Read More
-
Endocrinology Drugs Market by Therapy Area (Diabetes Drugs, Human Growth Hormone, Thyroid Hormone Disorders), Distribution Channel (Hospital pharmacies, Online pharmacies, Retail pharmacies) - Global Forecast 2024-2030
... 32.78 billion in 2023 and expected to reach USD 35.05 billion in 2024, at a CAGR 7.34% to reach USD 53.85 billion by 2030. Endocrinology drugs are medications that are used to treat disorders of ... Read More
-
Next Generation Contact Lenses & Visual Prostheses Market by Product (Diagnostic or monitoring contact lenses, Drug-eluting contact lenses, Therapeutic contact lenses), Disease (Age-Related Macular Degeneration, Diabetes, Glaucoma) - Global Forecast 2024-2030
... Lenses & Visual Prostheses Market size was estimated at USD 214.71 million in 2023 and expected to reach USD 254.45 million in 2024, at a CAGR 18.76% to reach USD 715.57 million by 2030. Next ... Read More
-
Diabetic Foot Ulcer Treatment Market by Treatment (Antibiotic Medications, Biologics, Therapy Devices), Ulcer Type (Ischemic Ulcers, Neuro-Ischemic Ulcers, Neuropathic Ulcers), End-use - Global Forecast 2024-2030
... USD 5.35 billion in 2023 and expected to reach USD 5.69 billion in 2024, at a CAGR 6.56% to reach USD 8.35 billion by 2030. The diabetic foot ulcer (DFU) treatment includes a range of ... Read More
-
Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Global Forecast 2024-2030
... 46.76 billion in 2024, at a CAGR 7.63% to reach USD 73.03 billion by 2030. The insulin market encompasses the production, distribution, and consumption of various insulin types used to treat diabetes mellitus, a chronic ... Read More
-
Insulin Resistance – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Insulin Resistance market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Insulin Resistance market report provides current treatment practices, emerging drugs, Insulin ... Read More
-
Dementia with Diabetes – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Dementia with Diabetes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Dementia with Diabetes market report provides current ... Read More
-
Diabetes Insipidus – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Diabetes Insipidus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetes Insipidus market report provides current treatment practices, emerging drugs, Diabetes ... Read More
-
Prediabetes – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Prediabetes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Prediabetes market report provides current treatment practices, emerging drugs, Prediabetes market share of the individual ... Read More
-
Diabetic Gastroparesis (DGp) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Diabetic Gastroparesis (DGp) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Gastroparesis (DGp) market report provides current ... Read More
-
Diabetic Neuropathic Pain – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Diabetic Neuropathic Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Neuropathic Pain market report provides current ... Read More
-
Global Self-Monitoring Blood Glucose Device Market Report by Product (Test Strips, Lancets, Blood Glucose Meters), Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), End-User (Hospital Pharmacies, Retail Pharmacies, Online Sales, and Diabetes Clinics & Centers), Regions and Company Analysis 2024-2032
... Centers), Regions and Company Analysis 2024-2032 The Self-Monitoring Blood Glucose Device Market will be US$ 21.05 billion by 2032 from US$ 11.68 Billion in 2023, with a CAGR of 6.76% during 2024 to 2032. Self-monitoring ... Read More
-
Diabetic Nephropathy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Diabetic Nephropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Nephropathy market report provides current treatment practices, emerging drugs, Diabetic ... Read More
-
Diabetic Ketoacidosis (DKA) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Diabetic Ketoacidosis (DKA) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Ketoacidosis (DKA) market report provides current ... Read More
-
Diabetic Eye Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Diabetic Eye Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Eye Disease market report provides current ... Read More
-
Chronic Pain Associated with Painful Diabetic Neuropathy – Market Insight, Epidemiology, and Market Forecast – 2034
... an in-depth understanding of the Chronic Pain Associated with Painful Diabetic Neuropathy, historical and forecasted epidemiology as well as the Chronic Pain Associated with Painful Diabetic Neuropathy market trends in the United States, EU5 (Germany, ... Read More
-
Diabetic Foot – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Diabetic Foot market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Diabetic Foot market report provides current treatment practices, emerging drugs, Diabetic ... Read More
-
Global Human Microbiome Market Report by Application (Therapeutics, Diagnostics) Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, Other Diseases) Product (Probiotics, Prebiotics, Symboitics, Other Products), Countries and Company Analysis, 2024-2032
... Human Microbiome Market will grow US$ 3.05 Billion by 2032 from US$ 0.72 Billion in 2023, with a CAGR of 17.48% during 2023-2032. The human microbiome is a collection of microorganisms found on and within ... Read More
-
Global Continuous Glucose Monitoring Market Report by Component (Sensors, Transmitters, Receivers), End-User (Hospitals, Homecare Settings, Others), Regions and Company Analysis 2024-2032
... to reach US$ 13.06 Billion by 2032, with a Compound Annual Growth Rate of 8.40% from 2024 to 2032. Continuous glucose monitoring is an effective tool that mechanically estimates blood glucose levels at day and ... Read More
-
Global Insulin Pen Market Report by Product (Disposable Insulin Pen and Reusable Insulin Pen), Disease types (Type 1 Diabetes and Type 2 Diabetes), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, and E-commerce) Regions and Company Analysis 2024-2032
... 2024-2032 The global insulin pen market will be US$ 10.71 billion by 2032 from US$ 6.27 billion in 2023, with a CAGR of 6.13% from 2024 to 2032. Insulin pens are the ultimate solution for ... Read More
-
Type 2 Diabetes – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Type 2 Diabetes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Type 2 Diabetes market report provides current ... Read More
-
Gestational Diabetes – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Gestational Diabetes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Gestational Diabetes market report provides current treatment practices, emerging drugs, Gestational ... Read More
-
Diabetic Neuropathic Pain- Pipeline Insight, 2024
... profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered ... Read More
Research Assistance
